Components and Timing of the ILDA Evaluation


Type of living donor/relationship to intended recipient (related, nonrelated, altruistic)

Knowledge/understanding of living donation process

Understanding of intended recipient’s medical condition as it relates to need for transplant and treatment options available

Signs of coercion or undue influence

Right to change mind at any time up until anesthesia/anticipated implications if living donation does not proceed as planned

Willingness and competence to donate

Possible financial or monetary gain, tangible or intangible

Understanding of medical, psychosocial, and financial risks

Support system including family and friends reaction/feelings

Occupational status and employer’s reaction/feelings

Any anticipated impact on lifestyle

Understanding/importance of long-term follow-up




References



1.

Rudow DL. The living donor advocate: a team approach to educate, evaluate, and manage donors across the continuum. Prog Transplant. 2009;19(1):64–70.PubMed

Apr 11, 2017 | Posted by in NEPHROLOGY | Comments Off on Components and Timing of the ILDA Evaluation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access